Vittal Vasista - Chief Financial Officer, Regenxbio Inc

As of July 29, 2021


Vittal Vasista Net Worth

  • Net worth is estimated to be at least $25.2M
  • Owns at least 113,640 units of Regenxbio Inc stock
  • Sold an estimated value of $18.13M in the last 6 years at Regenxbio Inc

Vittal Vasista Compensation at Regenxbio Inc in 2020

  • Earned a $453,188 salary
  • Received a total compensation of $1,881,639

Vittal Vasista Trading

  • Largest purchase of shares was 73,418 units , worth over $1M on November 5, 2018
  • Largest sale of shares was 73,418 units , worth over $5.15M on November 5, 2018
  • In total has made about 48 transactions over 6 years
  • Usually trades in January, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Vittal Vasista Mailing Address

  • Mailing address is C/o Regenxbio Inc. 9804 Medical Center Drive Rockville MD 20850 MD

Regenxbio Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Kenneth T. Mills 2020 $613,403 $16,388 $16,388 $16,388 $7,644,087
Kenneth T. Mills 2019 $595,537 $16,100 $16,100 $16,100 $6,147,269
Kenneth T. Mills 2018 $546,364 $15,813 $15,813 $15,813 $4,938,199
Vit Vasista 2020 $453,188 $16,388 $16,388 $16,388 $1,881,639
Vit Vasista 2019 $439,988 $16,100 $16,100 $16,100 $2,184,616
Vit Vasista 2018 $379,300 $15,813 $15,813 $15,813 $1,944,391
Curran Simpson 2020 $428,152 $16,388 $16,388 $16,388 $1,750,865
Curran Simpson 2019 $382,439 $16,100 $16,100 $16,100 $1,825,744
Curran Simpson 2018 $371,300 $14,844 $14,844 $14,844 $1,901,142
Olivier Danos, Ph.D. 2020 $433,908 $16,388 $16,388 $16,388 $1,805,415
Olivier Danos, Ph.D. 2019 $421,270 $16,100 $16,100 $16,100 $1,926,420
Olivier Danos, Ph.D. 2018 $409,000 $14,462 $14,462 $14,462 $1,613,769
Patrick J. Christmas 2020 $426,252 $16,388 $16,388 $16,388 $1,843,929
Patrick J. Christmas 2019 $405,954 $16,100 $16,100 $16,100 $1,833,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1590877/000156459021019415/rgnx-def14a_20210604.htm

Regenxbio Inc Insider Trading

  • The most recent transaction was 1,500 units sold on September 29, 2021 by Kenneth Mills worth over $63.28K
  • In the last 6 years, insiders at Regenxbio Inc sold an estimated value of $91.99M and bought an estimated value of $16.82M
  • The most active traders are Kenneth Mills, President and CEO,  Vittal Vasista, Chief Financial Officer,  and Curran Simpson, Chief Oper. & Tech. Officer
  • Insider trading is most common in January, with the busiest year in 2018
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1